<prompt> False about Aliskiren is:It is an oral renin inhibitorIt can result in hyperkalemiaIt is p-glycoprotein inhibitorBlocks conversion of angiotensinogen to Angiotensin I  <response>: Aliskiren: MOA: Potent competitive inhibitor of renin. Binds the active site of renin and blocks conversion of angiotensinogen to Angiotensin I. Pk: Bioavailability of aliskiren is low but still used orally as it has high affinity and potency. It is a substrate for P- glycoprotein Not the inhibitor. It can cause hyperkalemia by inhibiting the RAAS through which K is removed from the body. It is well tolerated in: Elderly population. Hepatic disease and renal insufficiency patients. Type 2 diabetes patients. 